MedPath

Safety and feasibility study of Cognitive Behavioral Therapy for Obsessive Compulsive Disorder – an open-label pilot study

Phase 3
Conditions
Obsessive Compulsive Disorder
Registration Number
JPRN-UMIN000008403
Lead Sponsor
Cognitive Behavioral Therapy Center OCD Study Group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1. No alcohol or substance use disorder in 6 months prior to the screening. 2. No other primary DSM-IV Axis I Disorders except Obsessive Compulsive Disorder in 6 months prior to the screening. 3. No comorbid of antisocial personality disorder. 4. No serious suicidal ideation at screening. 5. Evidence of unable to participate half or more of the intervention phase. 6. No past treatment of CBT for Obsessive Compulsive Disorder. 7. No major cognitive deficits for CBT treatment at screening. 8. No severe or unstable medical co-morbidities at screening. 9. Other relevant reason decided by the investigators.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Y-BOCS (Yale-Brown Obsessive Compulsive Scale)
Secondary Outcome Measures
NameTimeMethod
BDI-II(Beck Depression Inventory) SF-36(Quality of Life Scale) OASIS(Overall Anxiety Severity and Impairment Scale) EQ5D(Quality of Life Scale) QIDS-J(Quick Inventory of Depressive Symptomatology) GRID-HAMD(GRID-Hamilton Depression Rating Scale) MRI
© Copyright 2025. All Rights Reserved by MedPath